US Markets in:   hrs   min   sec

Set StockTrendNews.com as your Homepage! - Click Here Home     About Us     Subscribe     Contact
 
StockTrendNews (STN) Exclusive: Vertex Pharmaceuticals Incorporated
Enter Symbol or Keywords
x
StockDiagnostics.com Reiterates Vertex Pharmaceuticals' OPS Ranking of "8"   Stock Quote: (NasdaqNM:VRTX)
11/17/2009  
37.68 -0.22 -0.58% 23,856
StockDiagnostics.com Reiterates Vertex Pharmaceuticals' OPS Ranking of "8"  
Last Price Change % Chg Volume
Sarasota, FL, November 17, 2009-StockDiagnostics.com announced that it has reiterated its OPS Ranking of "8" for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Vertex Pharmaceuticals has had an O ... read full story  
Website Address: www.vpharm.com
Industry: Vaccine, Antibodies, Immunities
Most Recent STN Exclusives
x
02/09/2010
Cash Flow from Operations Improves 82% for News Corp.
02/09/2010
Revenue for Coach Increases by 3.25% even though Revenue for Apparel Industry Decreases by -22.4% over Latest 12 Months
02/09/2010
Free Cash Flow for News Corp. Reaches Two Year High
02/09/2010
Cash Flow from Operations Turns Positive for Siemens' First Quarter
02/09/2010
StockDiagnostics.com Has Issued a Cashless Earnings Warning For Energy XXI
02/08/2010
Second Quarter EBITDA Turns Positive for Harris
02/08/2010
Twelve Year High in EBITDA for Amazon.com
02/08/2010
Cash Flow from Operations for McCormick Reaches Fifteen Year High
02/08/2010
EBITDA for BMC Software Reaches Thirteen Year High
02/08/2010
EBITDA for CA Reaches Nine Year High
Interactive Chart: VRTX
x
More STN Exclusives for: VRTX
x
11/19/2009
EBITDA for Vertex Pharmaceuticals Reaches Twelve Year Low
11/17/2009
Vertex Pharmaceuticals bucks its Industry’s Revenue Increase of 7.82% with a Decline of -47.95%
11/17/2009
StockDiagnostics.com Reiterates Vertex Pharmaceuticals' OPS Ranking of "8"
... more VRTX exclusives
Other News Sources: VRTX
x
02/04/2010
VRTX: Q4 Adj EPS (66c) vs (85c) Beats (85c) Est
02/04/2010
Vertex Pharmaceuticals Reports 2009 Financial Results and Highlights Recent Progress in Hepatitis C and Cystic Fibrosis Development Programs
02/03/2010
Vertex Announces Results from Phase 2a Trial of VX-809 Targeting the Defective Protein Responsible for Cystic Fibrosis
... more VRTX news from other sources
Daily Market Updates
x
02/10/2010
Futures Flat After December Trade Deficit Widens to $40.2 Billion
Futures fell off their highs in the premarket after the December trade deficit was reported to have widened to $40.2 billion from $36.4 billion in November on a sharp gain in imports. That was much higher than the expected deficit of $36.8 billion. F ... read full story

30 Day Free Trial - MarketWatch Retirement Weekly

Free 30 Day Trial -MarketWatch Hulbert Interactive

Visit Tradesight



Sponsored Links
Attend a Free Webinar on How to Trade Stocks
InvestView.com
Increase Your Stock Market Performance by Using the News Management Interface that the Pros Use
Knobias.com

 
 
 
x


 
x
     
 
©2010 StockTrendNews.com
Disclaimer Terms of Sales Privacy About Us